Avantax Advisory Services Inc. increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 23.4% in the fourth quarter, HoldingsChannel reports. The firm owned 9,645 shares of the company’s stock after acquiring an additional 1,827 shares during the quarter. Avantax Advisory Services Inc.’s holdings in HealthEquity were worth $925,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently bought and sold shares of the company. KBC Group NV boosted its holdings in shares of HealthEquity by 16.1% in the 3rd quarter. KBC Group NV now owns 2,463 shares of the company’s stock valued at $202,000 after acquiring an additional 341 shares during the last quarter. Natixis Advisors LLC grew its position in HealthEquity by 29.8% during the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after purchasing an additional 48,009 shares during the period. Thrivent Financial for Lutherans raised its stake in shares of HealthEquity by 33.3% during the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock valued at $24,033,000 after buying an additional 73,404 shares during the last quarter. Swiss National Bank boosted its stake in shares of HealthEquity by 0.4% in the third quarter. Swiss National Bank now owns 169,900 shares of the company’s stock worth $13,906,000 after buying an additional 600 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in HealthEquity during the third quarter worth about $5,675,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.
HealthEquity Price Performance
HQY stock opened at $84.32 on Thursday. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a market capitalization of $7.31 billion, a PE ratio of 77.36, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The business has a 50 day simple moving average of $105.51 and a 200-day simple moving average of $95.59.
Wall Street Analyst Weigh In
View Our Latest Analysis on HQY
Insiders Place Their Bets
In other news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 2.20% of the company’s stock.
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
- Five stocks we like better than HealthEquity
- Golden Cross Stocks: Pattern, Examples and Charts
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What is the Nasdaq? Complete Overview with History
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Compound Interest and Why It Matters When Investing
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.